Basic Science Advisory Board Members

All advisory board members will assist with the annual stakeholder meeting; website outreach to professionals and patients; assist CCF to acquire CME funding to educate the general medical community; provide administrative guidance, assistance and strategic direction; other responsibilities to be determined.

Chair, Nabeel Bardeesy, PhD

Dr. Bardeesy is an Associate Professor of Medicine at Harvard Medical School and the Massachusetts General Hospital Cancer Center. He is the recipient of the Gallagher Endowed Chair in Gastrointestinal Cancer Research. His lab focuses on the interface of metabolism and epigenetic reprogramming in GI cancers and in the development of genetically engineered mouse models of human cancer. Dr. Bardeesy received both his BS and PhD in Biochemistry from McGill University in Canada, followed by a Postdoctoral Fellowship in Medical Oncology at the Dana-Farber Cancer Institute at Harvard Medical...

Wolfram Goessling, MD, PhD

Wolfram Goessling is an Associate Professor of Medicine and Associate Professor of Health Sciences and Technology at Harvard Medical School; he is a member of the Genetics and Gastroenterology Divisions at the Brigham and Women’s Hospital and of the Gastrointestinal Cancer Center at the Dana- Farber Cancer Institute, Principal Faculty at the Harvard Stem Cell Institute, and an Associate Member of the Broad Institute of MIT and Harvard. His laboratory seeks to understand molecular signals that regulate organ growth and regeneration. Dr. Goessling is using zebrafish as the primary model to discover novel regulatory pathways of liver and bile duct development and evaluate their importance for cancer formation. Dr. Goessling received his MD and PhD from the University of Witten/Herdecke in Germany, and completed...

Aram Hezel, MD

Aram Hezel, MD is an Associate Professor of Medicine, Vice-Chief of the Division of Hematology and Oncology, as well as the Director of the Pancreatic and Hepato-billiary Cancer Program at the Wilmot Cancer Center, University of Rochester and Strong Memorial Hospital. Dr. Hezel received his Medical Degree from the State University of New York at Buffalo Medical School. His residency was completed at Beth Israel Deaconess Medical Center, Medicine Fellowship was at Harvard Medical School and his Hematology/Oncology Fellowship was completed at Dana Farber /Partner Cancer Care in Boston, MA. Dr. Hezel is certified in Medical Oncology with a focus on treating patients diagnosed with gastrointestinal cancers including those of the pancreas and liver. He is focused on clinical research testing new therapies in...

Vice Chair, Ben Stanger, MD PhD

Dr. Stanger is an Associate Professor of Medicine and Cell and Developmental Biology at the University of Pennsylvania, where he is a practicing gastroenterologist. His laboratory studies the intersection between development of the GI tract and gastrointestinal cancers, with an emphasis on the pancreas, liver, and biliary tract. Dr. Stanger received his SB degree from MIT and his MD and PhD in Genetics from Harvard Medical School. His did a residency in Internal Medicine UCSF and a clinical fellowship in Gastroenterology at Massachusetts General Hospital, followed by a postdoctoral research fellowship at Harvard...

Matthew Vander Heiden, MD, PhD

Matthew Vander Heiden is the Eisen and Chang Associate Professor in the Koch Institute for Integrative Cancer Research and the Department of Biology at the Massachusetts Institute of Technology. He is also an Instructor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School. Dr. Vander Heiden received his MD and PhD degree from the University of Chicago. He also completed clinical training in Internal Medicine and Medical Oncology at the Brigham and Women’s Hospital / Dana-Farber Cancer Institute prior to completing a post-doctoral fellowship at Harvard Medical...

Pin It on Pinterest